Modeling blood-brain barrier partitioning using the electrotopological state

Journal of Chemical Information and Computer Sciences

Volumn 42, Issue 3, 2002, Pages 651-666

  Rose, Kimberly ^a   Hall, Lowell H ^a   Kier, Lemont B ^b  

^a EASTERN NAZARENE COLLEGE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROTOPOLOGICAL STATES;

AROMATIC COMPOUNDS; BLOOD; BRAIN; DRUG PRODUCTS; HYDROGEN BONDS; INFORMATION ANALYSIS;

MOLECULAR STRUCTURE;

ARTICLE; BLOOD BRAIN BARRIER; CHEMICAL MODEL; HYDROGEN BOND; PHARMACOKINETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BLOOD-BRAIN BARRIER; HYDROGEN BONDING; MODELS, CHEMICAL; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036557847     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010127n     Document Type: Article

References (44)

1. Crivori, P.; Cruciani, G.; Carrupt P.; Testa, B. Predicting blood-brain barrier permeation from three-dimensional molecular structure. J. Med. Chem. 2000, 43, 2204-2216.
2. Greet, J.; Erickson, J.W.; Baldwin, J.J.; Varney, M.D. Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Design. J. Med. Chem. 1994, 37, 1035-1054.
3. Bugg, C.E.; Carson, W.M.; Montgomery, J.A. Drugs by Design. Sci. Am. 1993, December, 92-98.
4. Kier, L.B.; Hall, L.H. Molecular Structure Description: The Electrotopological State; Academic Press: San Diego, 1999.
5. Kier, L.B.; Hall, L.H. Inhibition of Salicylamide Binding: An Electrotopological State Analysis. Med. Chem. Res. 1992, 2, 497-502.
6. Gough, J.D.; Hall, L.H. QSAR Models of the Antileukemic Potency of Carboquinones: Electrotopological State and Chi Indices. J. Chem. Inf. Comput. Sci. 1999, 39, 356-361.
7. Huuskonen, J. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology. J. Chem. Inf. Comput. Sci. 2000, 40, 773-777.
8. Huuskonen, J. QSAR Modeling with the Electrotopological State: TIBO Derivatives, J. Chem. Inf. Comput. Sci. 2001, 41, 425-429.
9. 50 Values for ACAT Inhibitors from Molecular Structure. J. Chem. Inf Comput. Sci. 2000, 40, 706-723.
10. Gozolbes, R.; Galvez, J.; Garcia-Domenech, R.; Derouin, F. Molecular Search of New Active Drugs Against Toxoplasma Gondii. SAR and QSAR Environ. Res. 1999, 10, 47-60.
11. (a) Young, R.C. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J. Med. Chem. 1988, 31, 656-671.
12. (b) Abraham, M.H.; Chadha H.S.; Mitchell, R.C. Hydrogen Bonding. Part 33. Factors that influence the distribution of solutes between blood and brain, J. Pharm. Sci. 1994, 83, 1257-1268.
13. (c) Salminem, T.; Pulli, A.; Taskinen, J. Relationship between immobilized artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs. J. Pharm. Biomed. Anal. 1997, 15, 469-677.
14. (d) Clark, D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J. Pharm. Sci. 1999, 83, 815-821.
15. (e) Luco, J.M. Prediction of brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J. Chem. Inf. Comput. Sci. 1999, 39, 396-404.
16. (f) Yazdanian, M.; Glynn, S.L. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J. Pharm. Sci. 1998, 87, 306-310.
17. (g) Grieg, N.H.; Brossi, A.; XueFeng, P.; Ingrain, D.K.; Soncrant, T. In New Concepts of a Blood-Brain Barrier; Greenwood J., et al., Eds.; Plenum: New York, 1995; pp 251-264.
18. (h) Lin, J.H.; Chen; I.; Lin, T. Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: a study of L-663, 581 and its metabolites in rats. J. Pharmacol. Exptl. Therapeut. 1994, 271, 1197-1202.
19. (i) Lombardo, F.; Blake, J.F.; Curatolo, W. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem., 1996, 39, 4750-4755.
20. (j) Van Belle, K.; Sarre, S.; Ebinger, G; Michotte, Y. Brain, liver, and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study. J. Pharmacol. Exptl. Therapeut. 1995, 272, 1217-1222.
21. (k) Calder, J.A.D.; Ganellin, R. Predicting the brain-penetrating capability of histaminergic compounds. Drug Design Discovery 1994, 11, 259-268.
22. KeserÜ, G.; Molnár, L. High-throughput prediction of blood-brain partitioning: a thermodynamic approach. J. Chem. Inf. Comput. Sci. 2001, 41, 120-128.
23. Parham, M.E.; Interactive Analysis, 6 Reuben Duren Way, Bedford, MA 01730; www.InterActiveAnalysis.com.
24. Hall, L.H.; Mohney, B.K.; Kier, L.B. Comparison of electrotopological state indexes with molecular orbital parameters: Inhibition of MAO by hydrazides. Quant. Struct.-Act. Relat. 1993, 12, 44-48.
25. Hall, L.H.; Kier, L.B. Electrotopological state indices for atom types: A novel combination of electronic, topological and valence state information. J. Chem. Inf. Comput. Sci. 1995, 35, 1039-1045.
26. Gough, J.D.; Hall, L.H. Modeling the Toxicity of Amide Herbicides using the Electrotopological State. J. Chem. Inf. Comput. Sci. 1999, 39, 356-361.
27. Gough, J.D.; Hall, L.H. QSAR Models of the Antileukemic Potency of Carboquinones: Electrotopological State and Chi Indices. Environ. Toc. Chem. 1999, 18, 1069-1075.
28. Kier, L.B.; Hall, L.H. Database Organization and Similarity Searching with E-State Indices. In Symposium on Computer Methods for Structure Representation; Kluwer Academic Publishing Co.: Amsterdam, The Netherlands, 2001; pp 33-49.
29. Hall, L.H.; Kier, L.B. The Electrotopological State: Structure Modeling for QSAR and Database Analysis. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 491-562.
30. Kier, L.B.; Hall, L.H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press: John Wiley and Sons: Chichester, U.K., 1986.
31. Hall, L.H.; Kier, L.B. The Molecular Connectivity Chi Indexes and Kappa Shape Indexes in Structure-Property Relations. In Reviews of Computational Chemistry; Boyd, D., Lipkowitz, K., Eds.; VCH Publishers: 1991; Chapter 9, pp 367-422.
32. Hall, L.H.; Kier, L.B. Molecular Connectivity Chi Indices for Database Analysis and Structure-Property Modeling. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 307-360.
33. Kier, L.B.; Hall, L.H. The Kappa Indices for Modeling Molecular Shape and Flexibility. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 455-490.
34. Maw, H.H.; Hall, L.H. E-State modeling of dopamine transporter binding. Validation of model for a small data set. J. Chem. Inf. Comput. Sci., 2000, 40, 1270-1275.
35. (a) Maw, H.H.; Hall, L.H. E-State modeling of corticosteroid binding affinity. Validation of model for a small data set. J. Chem. Inf. Comput. Sci. 2001, 41, 1248-1254.
36. (b) Maw, H.H.; Hall, L.H. E-State modeling of HIV-1 protease inhibitor binding independent of 3D information. J. Chem. Inf. Comput. Sci. 2002, 42, 290-298.
37. (a) Hall, L.H.; Kier, L.B. The E-State as the basis for molecular structure space definition and structure similarity. J. Chem. Inf. Comput. Sci. 2000, 40, 784-791.
38. (b) Kier, L.B.; Hall, L.H. Database Organization and Searching with E-State Indices. SAR QSAR Environ. Sci. 2001, 12, 55-74.
39. ChemDraw, ver 4.5; CambridgeSoft: Cambridge, MA 02139.
40. Molconn-Z, ver 3.50; available from Hall Associates Consulting, 2 Davis Street, Quincy, MA, 02170; also from EduSoft, LC, P.O. Box 1811, Ashland, VA 23005; and SciVision, Inc., 200 Wheeler Road, Burlington, MA 01803.
41. SAS, ver 8.0; SAS Institute: Cary, NC 27513.
42. Hall, L.H.; Kier, L.B. Molecular Similarity Based on Novel Atom Type Electrotopological State Indices. J. Chem. Inf. Comput. Sci. 1995, 35, 1074-1080.
43. (a) Kier, L.B.; Hall, L.H. Intermolecular accessibility: The meaning of molecular connectivity. J. Chem. Inf. Comput. Sci. 2000, 40, 792-795.
44. (b) Kier, L.B.; Hall, L.H. Molecular connectivity: Intermolecular accessibility and encounter simulation. J. Mol. Graphics Model. 2001, 20, 76-83.